Asia Pacific Enteral and Parenteral Medical Nutrition Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - Regional Analysis By Indication [Elderly, Gastrointestinal Disorders (IBD, IBS, and Others), Diabetes, Cancer, Respiratory Disorders, Alzheimer’s Disease, Dementia, Renal Disease, Liver Failure, Post COVID-19, and Other Indications], Nutrition Type (Supplemental and Sole Source), Form (Liquid, Powder, and Semi Solid), Product Type (General and Disease Specific), Route of Administration (Oral, Tube Feed, and Parenteral), Age Group (Above 60 Years, 18-60 Years, 3-18 Years, and Below 3 Years), and Distribution Channel (Hospital Pharmacies, Retail Stores, E-Commerce, and Others)

No. of Pages: 348    |    Report Code: BMIRE00028869    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia Pacific Enteral and Parenteral Medical Nutrition Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Asia Pacific Enteral and Parenteral Medical Nutrition Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Asia Pacific Enteral and Parenteral Medical Nutrition Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Rising Number of Gastrointestinal Diseases in geriatric population is propelling the market growth
5.2 Market Opportunities
  • 5.2.1 Increasing Cases of Malnutrition and Premature Births in emerging nations is augmenting the demand for enteral and parenteral nutrition products
5.3 Future Trends
  • 5.3.1 Growing Strategic Initiatives by Key Companies
5.4 Impact of Drivers and Restraints

6. Asia Pacific Enteral and Parenteral Medical Nutrition Market Regional Analysis

6.1 Asia Pacific Enteral and Parenteral Medical Nutrition Market Overview
6.2 Asia Pacific Enteral and Parenteral Medical Nutrition Market Revenue 2021-2028 (US$ Million)
6.3 Asia Pacific Enteral and Parenteral Medical Nutrition Market Forecast Analysis

7. Asia Pacific Enteral and Parenteral Medical Nutrition Market Analysis – by Indication

7.1 Elderly
  • 7.1.1 Overview
  • 7.1.2 Elderly: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Gastrointestinal Disorders
  • 7.2.1 Overview
  • 7.2.2 Gastrointestinal Disorders: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Diabetes
  • 7.3.1 Overview
  • 7.3.2 Diabetes: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Cancer
  • 7.4.1 Overview
  • 7.4.2 Cancer: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Respiratory Disorders
  • 7.5.1 Overview
  • 7.5.2 Respiratory Disorders: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Alzheimer's Disease
  • 7.6.1 Overview
  • 7.6.2 Alzheimer's Disease: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.7 Dementia
  • 7.7.1 Overview
  • 7.7.2 Dementia: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.8 Renal Disease
  • 7.8.1 Overview
  • 7.8.2 Renal Disease: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.9 Liver Failure
  • 7.9.1 Overview
  • 7.9.2 Liver Failure: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.10 Post COVID-19
  • 7.10.1 Overview
  • 7.10.2 Post COVID-19: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.11 Other Indications
  • 7.11.1 Overview
  • 7.11.2 Other Indications: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2031 (US$ Million)

8. Asia Pacific Enteral and Parenteral Medical Nutrition Market Analysis – by Nutrition Type

8.1 Supplemental
  • 8.1.1 Overview
  • 8.1.2 Supplemental: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Sole Source
  • 8.2.1 Overview
  • 8.2.2 Sole Source: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)

9. Asia Pacific Enteral and Parenteral Medical Nutrition Market Analysis – by Form

9.1 Liquid
  • 9.1.1 Overview
  • 9.1.2 Sole Source: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Powder
  • 9.2.1 Overview
  • 9.2.2 Sole Source: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Semi Solid
  • 9.3.1 Overview
  • 9.3.2 Sole Source: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)

10. Asia Pacific Enteral and Parenteral Medical Nutrition Market – Asia-Pacific Analysis

10.1 Asia-Pacific
  • 10.1.1 Asia Pacific Enteral and Parenteral Medical Nutrition Market Breakdown, by Key Country, 2024 and 2028 (%)
  • 10.1.1.1 Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 China: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 China: Asia Pacific Enteral and Parenteral Medical Nutrition Market Breakdown, by Indication
    • 10.1.1.1.2 China: Asia Pacific Enteral and Parenteral Medical Nutrition Market Breakdown, by Nutrition Type
    • 10.1.1.1.3 China: Asia Pacific Enteral and Parenteral Medical Nutrition Market Breakdown, by Form
  • 10.1.1.2 India: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 India: Asia Pacific Enteral and Parenteral Medical Nutrition Market Breakdown, by Indication
    • 10.1.1.2.2 India: Asia Pacific Enteral and Parenteral Medical Nutrition Market Breakdown, by Nutrition Type
    • 10.1.1.2.3 India: Asia Pacific Enteral and Parenteral Medical Nutrition Market Breakdown, by Form
  • 10.1.1.3 Japan: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 Japan: Asia Pacific Enteral and Parenteral Medical Nutrition Market Breakdown, by Indication
    • 10.1.1.3.2 Japan: Asia Pacific Enteral and Parenteral Medical Nutrition Market Breakdown, by Nutrition Type
    • 10.1.1.3.3 Japan: Asia Pacific Enteral and Parenteral Medical Nutrition Market Breakdown, by Form
  • 10.1.1.4 Australia: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.4.1 Australia: Asia Pacific Enteral and Parenteral Medical Nutrition Market Breakdown, by Indication
    • 10.1.1.4.2 Australia: Asia Pacific Enteral and Parenteral Medical Nutrition Market Breakdown, by Nutrition Type
    • 10.1.1.4.3 Australia: Asia Pacific Enteral and Parenteral Medical Nutrition Market Breakdown, by Form
  • 10.1.1.5 Rest of Asia-Pacific : Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.5.1 Rest of Asia-Pacific : Asia Pacific Enteral and Parenteral Medical Nutrition Market Breakdown, by Indication
    • 10.1.1.5.2 Rest of Asia-Pacific : Asia Pacific Enteral and Parenteral Medical Nutrition Market Breakdown, by Nutrition Type
    • 10.1.1.5.3 Rest of Asia-Pacific : Asia Pacific Enteral and Parenteral Medical Nutrition Market Breakdown, by Form

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Asia Pacific Enteral and Parenteral Medical Nutrition Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Abbott Laboratories
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 B. Braun SE
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Baxter International Inc
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Fresenius Kabi AG
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Nestle SA
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Nutricia International BV
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - Asia Pacific Enteral and Parenteral Medical Nutrition Market

  1. Abbott Laboratories
  2. B. Braun SE
  3. Baxter International Inc
  4. Fresenius Kabi AG
  5. Nestle SA
  6. Nutricia International BV
asia-pacific-enteral-and-parenteral-medical-nutrition-market